More articles from MTA I: Radiopharmaceutical Therapy Posters

You have access
Accurate assessment of long-term nephrotoxicity after therapy with 177Lu-octreotate
Amir Sabet, Khaled Ezziddin, Karl Reichmann, Hojjat Ahmadzadehfar, Torjan Haslerud, Stefan Guhlke, Hans Jürgen Biersack and Samer Ezziddin

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1186;
You have access
Radiation dosimetry of glass versus resin Y-90 microsphere radioembolization in patients with colorectal liver metastases
Vamsi Kunam, Sankaran Shrikanthan and Shyam Srinivas

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1203;
You have access
Therapeutic response assessment in radio-immunotherapy: Comparison of metabolic (PERCIST) and anatomic (RECIST) tumor response criteria
Jure Murgic, Yuni Dewaraja, Ka kit Wong, Mark Kaminski and Anca Avram

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1197;
You have access
Molecular radiotherapy with 131 iodine metaiodobenzylguanidine in malignant pheochromocytomas/paragangliomas - Are we making a difference?
R. Chakravartty, Gillian Vivian, B. Corcoran, S. Al-Shahwan, L. Devlin, Muriel Buxton-Thomas and N. Mulholland

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1191;
You have access
Can peptide receptor radionuclide therapy be safely applied in florid bone metastases of gastroenteropancreatic neuroendocrine tumours?
Amir Sabet, Charlotte Yong-Hing, Khaled Ezziddin, Hojjat Ahmadzadehfar, Stefan Guhlke, Frank Gruenwald, Hans Jürgen Biersack and Samer Ezziddin

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1183;
You have access
Pathomechanism and identification of new therapeutic strategies in radiation induced nephropathy after Lu-177-DOTATATE therapy
Harun Ilhan, Hao Wang, Franz Gildehaus, Carmen Wängler, Tanja Herrler, Heidrun Zankl, Peter Bartenstein, Marcus Hacker and Alexander Haug

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1187;
You have access
Using F-18-BPA imaging to evaluate recurrent head-and-neck cancer treated with boron neutron capture therapy
Shyh-Jen Wang, Ling-Wei Wang, Bang-Hung Yang, Ko-Han Lin and Fong-In Chou

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1196;
You have access
Response and long-term survival of GEP NET G1/2 after PRRT with Lu177-octreotate
Samer Ezziddin, Mared Attassi, Charlotte Yong-Hing, Amir Sabet, Hojjat Ahmadzadehfar, Winfried Willinek, Frank Gruenwald, Stefan Guhlke and Hans Jürgen Biersack

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1175;
You have access
177Lu-EDTMP for bone pain palliation in patients with bone metastases: Pharmacokinetics and toxicity evaluation using dose escalation schedule
Shabana Saeed, John Zaknun, Ghazal Jameel, Naseer Ahmed, Javaid Irfan, Shazia Fatima, Ahmad Qureshy, Muhammad Shahzad Afzal and Giuliano Mariani

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1211;
You have access
The role of peptide receptor radionuclide therapy in patients with lung neuroendocrine tumours
Angelina Filice, Alessandro Fraternali, Federica Fioroni, Armando Froio, Maria Liberata Di Paolo, Massimiliano Casali, Massimo Roncali, Elisa Grassi, Mattia Asti and Annibale Versari

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1180;

Main menu

User menu

Search

More articles from MTA I: Radiopharmaceutical Therapy Posters

Pages